Generic Competition And Pharmaceutical Patent Strategies: A Sequel
October 2008
in “
Journal of Intellectual Property Law & Practice
”
pharmaceutical patents generic competition patent strategies citalopram escitalopram enantiomer racemate Swiss form claim European Patent Office EPO second pharmaceutical use dosage regime method of treatment pharma patents generic drugs patent tactics Celexa Lexapro drug enantiomer drug racemate Swiss claim second use dosage plan treatment method
Studysummary The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer